Evidence Hub

Evaluation of the TG-43 formalism for intraoperative radiotherapy dosimetry in glioblastoma treatment

Ayala Alvarez DS, Watson PGF, Popovic M, Heng VJ, Evans MDC, Panet-Raymond V, Seuntjens J

Medical physics, 2025

20 participants · 2 citations

Abstract

Background: Intraoperative radiation therapy (IORT) using the INTRABEAM system has shown promise in glioblastoma treatment. However, accurate dosimetry remains challenging due to the low-energy photons used and the heterogeneity of tissues in the brain. Current clinical practice relies on the TARGIT method, but more robust approaches, including the TG-43 formalism and Monte Carlo (MC) simulations, warrant investigation for potential improvements in dose calculation accuracy.

Purpose: To evaluate the TG-43 dosimetry formalism for IORT dose calculations in glioblastoma treatment using the INTRABEAM system, comparing it with the TARGIT method and MC simulations.

Methods: We analyzed the dose distributions in 20 patients from the INTRAGO trial. The TG-43 formalism was validated against MC simulations in water ( MCw${\rm MC}_{\rm w}$ ) using global/local dose differences and gamma analysis (1%/1mm). Organ at risk (OAR) doses were calculated using TG-43, TARGIT, MCw${\rm MC}_{\rm w}$ , and MC in heterogeneous media ( MChet${\rm MC}_{\rm het}$ ). Combined IORT and external beam radiotherapy (EBRT) doses were evaluated.

Results: TG-43 showed good agreement with MCw${\rm MC}_{\rm w}$ , with a 98.0% gamma pass rate. The mean global dose difference was 0.07% ±$\pm$ 0.29%, with TG-43 slightly overestimating dose compared to MCw${\rm MC}_{\rm w}$ . For OAR dose comparisons using TG-43 as reference, TARGIT underestimated doses by 0.1%-1.7%, while MChet${\rm MC}_{\rm het}$ showed larger…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free